Duloxetine for painful diabetic neuropathy and fibromyalgia pain: Systematic review of randomised trials

BMC Neurology

Volumn 8, Issue , 2008, Pages

  Sultan, Asquad ^a   Gaskell, Helen ^b   Derry, Sheena ^b   Andrew, R Andrew ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DULOXETINE; IMIPRAMINE; PARACETAMOL; PLACEBO; VENLAFAXINE; ADRENERGIC RECEPTOR AFFECTING AGENT; THIOPHENE DERIVATIVE;

ANALGESIA; CLINICAL TRIAL; COCHRANE LIBRARY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DECREASED APPETITE; DIABETIC NEUROPATHY; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMBASE; EVIDENCE BASED MEDICINE; FIBROMYALGIA; HUMAN; LABORATORY TEST; MEDLINE; NAUSEA; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT DURATION; VITAL SIGN; PAIN; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADRENERGIC UPTAKE INHIBITORS; DIABETIC NEUROPATHIES; FIBROMYALGIA; HUMANS; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIOPHENES; TREATMENT OUTCOME;

EID: 51349119038     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-8-29     Document Type: Review

References (50)

1. Jensen MP Chodroff MJ Dworkin RH The impact of neuropathic pain on health-related quality of life: Review and implications Neurology 2007, 68:1178-1182. 10.1212/01.wnl.0000259085.61898.9e 17420400
2. Jadad AR Carroll D Glynn CJ Moore RA McQuay HJ Morphine responsiveness of chronic pain: Double-blind randomised crossover study with patient-controlled analgesia Lancet 1992, 339:1367-1371. 10.1016/ 0140-6736(92)91194-D 1350803
3. McQuay H Carroll D Jadad AR Wiffen P Moore A Anticonvulsant drugs for management of pain: A systematic review BMJ 1995, 311:1047-1052. 7580659
4. McQuay HJ Tramer M Nye BA Carroll D Wiffen PJ Moore RA A systematic review of antidepressants in neuropathic pain Pain 1996, 68:217-227. 10.1016/S0304-3959(96)03140-5 9121808
5. Attal N Cruccu G Haanpaa M Hansson P Jensen TS Nurmikko T Sampaio C Sindrup S Wiffen P EFNS Task Force EFNS guidelines on pharmacological treatment of neuropathic pain Eur J Neurol 2006, 13:1153-1169. 10.1111/ j.1468-1331.2006.01511.x 17038030
6. Hall GC Carroll D Parry D McQuay HJ Epidemiology and treatment of neuropathic pain: The UK primary care perspective Pain 2006, 122:156-162. 10.1016/j.pain.2006.01.030 16545908
7. McQuay HJ Smith LA Moore RA Chronic pain Health Care Needs Assessment, 3rd series Oxford: Radcliffe Publishing Stevens A, Raftery J, Mant J, Simpson S 2007:519-600.
8. Eisenberg E McNicol ED Carr DB Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials JAMA 2005, 293:3043-3052. 10.1001/jama.293.24.3043 15972567
9. Finnerup NB Otto M McQuay HJ Jensen TS Sindrup SH Algorithm for neuropathic pain treatment: An evidence based proposal Pain 2005, 118:289-305. 10.1016/j.pain.2005.08.013 16213659
10. Hempenstall K Nurmikko TJ Johnson RW A'Hern RP Rice AS Analgesic therapy in postherpetic neuralgia: A quantitative systematic review PLoS Med 2005, 2:e164. 1181872 16013891 10.1371/journal.pmed.0020164
11. Khaliq W Alam S Puri N Topical lidocaine for the treatment of postherpetic neuralgia Cochrane Database Syst Rev 2007, 2:CD004846. 17443559
12. Mason L Moore RA Derry S Edwards JE McQuay HJ Systematic review of topical capsaicin for the treatment of chronic pain BMJ 2004, 328:991-994. 404499 15033881 10.1136/bmj.38042.506748.EE
13. Saarto T Wiffen PJ Antidepressants for neuropathic pain Cochrane Database Syst Rev 2007, 4:CD005454. 17943857
14. Wiffen P Collins S McQuay H Carroll D Jadad A Moore A Anticonvulsant drugs for acute and chronic pain Cochrane Database Syst Rev 2005, 3:CD001133. 16034857
15. Wiffen PJ McQuay HJ Edwards JE Moore RA Gabapentin for acute and chronic pain Cochrane Database Syst Rev 2005, 3:CD005452. 16034978
16. Wiffen PJ McQuay HJ Moore RA Carbamazepine for acute and chronic pain Cochrane Database Syst Rev 2005, 3:CD005451. 16034977
17. Suzuki R Rygh LJ Dickenson AH Bad news from the brain: Descending 5-HT pathways that control spinal pain processing Trends Pharmacol Sci 2004(2512):613-617. 10.1016/j.tips.2004.10.002
18. Kajdasz DK Iyengar S Desaiah D Backonja MM Farrar KT Fishbain DA Jensen TS Rowbotham MC Sang CN Ziegler D McQuay HJ Duloxetine for the management of diabetic peripheral neuropathic pain: Evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies Clin Ther 2007, 29:2536-2546. 10.1016/j.clinthera.2007.12.002 18164920
19. Eli Lilly and Company Clinical Trial Registry http://www.lillytrials.com
20. Jadad AR Moore RA Carroll D Jenkinson C Reynolds DJ Gavaghan DJ McQuay HJ Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996, 17:1-12. 10.1016/ 0197-2456(95)00134-4 8721797
21. Smith LA Oldman AD McQuay HJ Moore RA Teasing apart quality and validity in systematic reviews: An example from acupuncture trials in chronic neck and back pain Pain 2000, 86:119-132. 10.1016/S0304-3959(00)00234-7 10779669
22. Moher D Cook DJ Eastwood S Olkin I Rennie D Stroup DF Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of meta-analyses Lancet 1999, 354:1896-1900. 10.1016/S0140-6736(99)04149-5 10584742
23. Moore RA Gavaghan D Tramèr MR Collins SL McQuay HJ Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects Pain 1998, 78:209-216. 10.1016/S0304-3959(98)00140-7 9870574
24. Gavaghan DJ Moore RA McQuay HJ An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data Pain 2000, 85:415-424. 10.1016/S0304-3959(99)00302-4 10781914
25. Higgins J Thompson S Deeks J Altman D Statistical heterogeneity in systematic reviews of clinical trials: A critical appraisal of guidelines and practice J Health Serv Res Policy 2002, 7:51-61. 10.1258/ 1355819021927674 11822262
26. L'Abbe KA Detsky AS O'Rourke K Meta-analysis in clinical research Ann Intern Med 1987, 107:224-233. 3300460
27. Morris JA Gardner MJ Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates Br Med J (Clin Res Ed) London: British Medical Journal 1995, 296:6632-1313. 1316
28. Cook RJ Sackett DL The number needed to treat: A clinically useful measure of treatment effect BMJ 1995, 310:452-454. 7873954
29. Tramèr MR Reynolds DJM Moore RA McQuay HJ Impact of covert duplicate publication on meta-analysis: A case study BMJ 1997, 315:635-639. 2127450 9310564
30. Arnold LM Lu Y Crofford LJ Wohlreich M Detke MJ Iyengar S Goldstein DJ A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder Arthritis Rheum 2004, 50:2974-2984. 10.1002/art.20485 15457467
31. Arnold LM Rosen A Pritchett YL D'Souza DN Goldstein DJ Iyengar S Wernicke JF A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder Pain 2005, 119:5-15. 10.1016/ j.pain.2005.06.031 16298061
32. Goldstein DJ Lu Y Detke MJ Lee TC Iyengar S Duloxetine vs. placebo in patients with painful diabetic neuropathy Pain 2005, 116:109-118. 10.1016/j.pain.2005.03.029 15927394
33. Raskin J Pritchett YL Wang F D'Souza DN Waninger AL Iyengar S Wernicke JF A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain Pain Med 2005, 6:346-356. 10.1111/j.1526-4637.2005.00061.x 16266355
34. Wernicke JF Pritchett YL D'Souza DN Waninger A Tran P Iyengar S Raskin J A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain Neurology 2006, 67:1411-1420. 10.1212/ 01.wnl.0000240225.04000.1a 17060567
35. Russell IJ Mease PJ Smith TR Kajdasz DK Wohlreich MM Detke MJ Walker DJ Chappell AS Arnold LM Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial Pain 2008, 136:432-444. 10.1016/j.pain.2008.02.024 18395345
36. Brannan SK Mallinckrodt CH Brown EB Wohlreich MM Watkin JG Schatzberg AF Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder J Psychiatr Res 2005, 39:43-53. 10.1016/j.jpsychires.2004.04.011 15504423
37. Fava M Mallinckrodt CH Detke MJ Watkin JG Wohlreich MM The effect of duloxetine on painful physical symptoms in depressed patients: Do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004, 65:521-530. 15119915
38. Goldstein DJ Lu Y Detke MJ Hudson J Iyengar S Demitrack MA Effects of duloxetine on painful physical symptoms associated with depression Psychosomatics 2004, 45:17-28. 10.1176/appi.psy.45.1.17 14709757
39. Perahia DG Kajdasz DK Walker DJ Raskin J Tylee A Duloxetine 60 mg once daily in the treatment of milder major depressive disorder Int J Clin Pract 2006, 60:613-620. 1473178 16700869 10.1111/j.1368-5031.2006.00956.x
40. Raskin J Wiltse CG Siegal A Sheikh J Xu J Dinkel JJ Rotz BT Mohs RC Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial Am J Psychiatry 2007, 164:900-909. 10.1176/ appi.ajp.164.6.900 17541049
41. Russell JM Weisberg R Fava M Hartford JT Erickson JS D'Souza DN Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms Depress Anxiety 2007. DOI 10.1002/da20337 17587217
42. Moore A McQuay H Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press 2006.
43. Bech P Kajdasz DK Porsdal V Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder Psychopharmacology 2006, 188:273-280. 10.1007/s00213-006-0505-1 16960699
44. Perahia DG Kajdasz DK Walker DJ Raskin J Tylee A Duloxetine 60 mg once daily in the treatment of milder major depressive disorder Int J Clin Pract 2006, 60:613-620. 1473178 16700869 10.1111/j.1368-5031.2006.00956.x
45. Wise TN Wiltse CG Iosifescu DV Sheridan M Xu JY Raskin J The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity Int J Clin Pract 2007, 61:1283-1293. 2408656 17590215 10.1111/j.1742-1241.2007.01476.x
46. Raskin J Wang F Pritchett YL Goldstein DJ Duloxetine for patients with diabetic peripheral neuropathic pain: A 6-month open-label safety study Pain Med 2006, 7:373-385. 10.1111/j.1526-4637.2006.00207.x 17014595
47. Wernicke JF Wang F Pritchett YL Smith TR Raskin J D'Souza DN Iyengar S Chappell AS An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain Pain Med 2007, 8:503-513. 10.1111/ j.1526-4637.2006.00258.x 17716324
48. Wernicke J Lledó A Raskin J Kajdasz DK Wang F An evaluation of the cardiovascular safety profile of duloxetine: Findings from 42 placebo-controlled studies Drug Saf 2007, 30:437-455. 10.2165/ 00002018-200730050-00007 17472422
49. Spielmans GI Duloxetine does not relieve painful physical symptoms in depression: A meta-analysis Psychother Psychosom 2008, 77:12-16. 10.1159/ 000110055 18087203
50. Dworkin RH O'Connor AB Backonja M Farrar JT Finnerup NB Jensen TS Kalso EA Loeser JD Miaskowski C Nurmikko TJ Portenoy RK Rice AS Stacey BR Treede RD Turk DC Wallace MS Pharmacologic management of neuropathic pain: Evidence-based recommendations Pain 2007, 132:237-251. 10.1016/ j.pain.2007.08.033 17920770